Effect of baicalein on the expression of VIP in extravillous cytotrophoblasts infected with human cytomegalovirus in vitro

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 3, 2013, Pages 406-411

  Qiao, Yuan ^a   Fang, Jian Guo ^a   Xiao, Juan ^a   Liu, Tao ^b   Liu, Jing ^a   Zhang, Yan Li ^a   Chen, Su Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Tai'an Central Hospital   (China)

Author keywords

baicalein; extravillous cytotrophoblasts; human cytomegalovirus; vasoactive intestinal peptide

Indexed keywords

ANTIVIRUS AGENT; BAICALEIN; FLAVANONE DERIVATIVE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CELL LINE; CYTOLOGY; CYTOMEGALOVIRUS; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; TROPHOBLAST; VIROLOGY; VIRUS INACTIVATION;

ANTIVIRAL AGENTS; CELL LINE; CYTOMEGALOVIRUS; FLAVANONES; HUMANS; TROPHOBLASTS; VASOACTIVE INTESTINAL PEPTIDE; VIRUS INACTIVATION;

EID: 84879288403     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1132-9     Document Type: Article

References (30)

1. Ross SA, Boppana SB. Congenital cytomegalovirus infection: outcome and diagnosis. Semin Pediatr Infect Dis, 2005,16(1):44-49
2. Raynor BD. Cytomegalovirus infection in pregnancy. Semin Perinatol, 1993,17(6):394-402
3. Stagno S, Pass RF, Cloud G, et al. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA, 1986,256(14):1904-1908
4. Cordier AG, Guitton S, Vauloup-Fellous C, et al. Awareness of cytomegalovirus infection among pregnant women in France. J Clin Virol, 2012,53(4):332-337
5. Kumpel BM, Manoussaka MS. Placental immunology and maternal alloimmune responses. Vox Sang, 2012,102(1): 2-12
6. Fraccaroli L, Grasso E, Hauk V, et al. Defects in the vasoactive intestinal peptide (VIP)/VPAC system during early stages of the placental-maternal leucocyte interaction impair the maternal tolerogenic response. Clin Exp Immunol, 2012,170(3):310-320
7. Delgado M, Ganea D. Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Amino Acids, 2011
8. Warning JC, Mccracken SA, Morris JM. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction, 2011,141(6): 715-724
9. Fraccaroli L, Alfieri J, Larocca L, et al. VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells. Br J Pharmacol, 2009,156(1):116-126
10. Griffiths PD. The 2001 Garrod lecture. The treatment of cytomegalovirus infection. J Antimicrob Chemother, 2002, 49(2):243-253
11. Nassetta L, Kimberlin D, Whitley R. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother, 2009, 63(5):862-867
12. Gao Y, Gu ZL, Jiang XG, et al. The new research of baicalein pharmacology. Shizhen Guoyi Guoyao (Chinese). 2010(7):1765-1767
13. Yang LP, Yang YM, Yang J, et al. Observations of teratogenic effects of scutellaria baicalensis georgi on embryos of rats. Zhongguo Bijiao Yixue Zazhi (Chinese). (5).
14. Evers DL, Chao CF, Wang X, et al. Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action. Antiviral Res, 2005,68(3): 124-134
15. Cotin S, Calliste CA, Mazeron MC, et al. Eight flavonoids and their potential as inhibitors of human cytomegalovirus replication. Antiviral Res, 2012,96(2):181-186
16. Tarrade A, Lai KR, Malassine A, et al. Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta. Lab Invest, 2001,81(9):1199-1211
17. Zhang L, Zhang W, Shao C, et al. Establishment and characterization of a spontaneously immortalized trophoblast cell line (HPT-8) and its hepatitis B virus-expressing clone. Hum Reprod, 2011,26(8):2146-2156
18. Liu T, Zheng X, Chen J, et al. Effect of human cytomegalovirus on invasive capability of early pregnant extravillous cytotrophoblasts. J Huazhong Univ Sci Technolog [Med Sci], 2011,31(6):819-823
19. Zhao JJ, Chen JJ, Liu T, et al. Anti-viral effects of urosolic acid on guinea pig cytomegalovirus in vitro. J Huazhong Uni Sci Technolog [Med Sci], 2012 (6):883-887
20. Zhao JJ, Chen SH, Fang JG, et al. Antiviral effects of obeanolic acid on guniea cytomegalovirus in vitro. Lishizhen Med Materia Medica Res (Chinese). 2011 (12): 2862-2864
21. Yinon Y, Farine D, Yudin MH, et al. Cytomegalovirus infection in pregnancy. J Obstet Gynaecol Can, 2010,32(4):348-354
22. Mccarthy FP, Giles ML, Rowlands S, et al. Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant. Cochrane Database Syst Rev, 2011(3): D8371
23. Stenqvist AC, Chen T, Hedlund M, et al. An efficient optimized method for isolation of villous trophoblast cells from human early pregnancy placenta suitable for functional and molecular studies. Am J Reprod Immunol, 2008, 60(1):33-42
24. Dong M, Ding G, Zhou J, et al. The effect of trophoblasts on T lymphocytes: possible regulatory effector molecules - a proteomic analysis. Cell Physiol Biochem, 2008, 21(5-6):463-472
25. Ramhorst R, Fraccaroli L, Aldo P, et al. Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells. Am J Reprod Immunol, 2012,67(1): 17-27
26. Said S I, Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science, 1970,169(3951):1217-1218
27. Spong C Y, Lee SJ, Mccune SK, et al. Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide. Endocrinology, 1999,140(2):917-924
28. Marzioni D, Fiore G, Giordano A, et al. Placental expression of substance P and vasoactive intestinal peptide: evidence for a local effect on hormone release. J Clin Endocrinol Metab, 2005,90(4):2378-2383
29. Zhao JJ. Effective constituents of TCM anti-GPCMV infection experimental study in vitro[D]. Huazhong Uni, 2011
30. Cristea IM, Moorman NJ, Terhune SS, et al. Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein. J Virol, 2010,84(15):7803-7814